anti cancer medicine

Brukinsa 80 mg Capsule (Zanubrutinib): Global Supply & Clinical Profile Are you searching for a reliable international partner for high-quality oncology treatments? ERNEST IMPEX, a premier pharmaceutical exporter from India and part of the Ernest Pharmaceutical Pvt. Ltd. group, specializes in the bulk supply and export of Brukinsa 80 mg Capsule. We bridge the gap between world-class Indian pharmaceutical logistics and global healthcare systems, ensuring life-saving treatments reach hospitals and patients worldwide. 📋 PRESCRIPTION MEDICINE IS YES 🏥 Clinical Overview: Understanding Brukinsa 80 mg Brukinsa contains Zanubrutinib, a potent, next-generation small-molecule inhibitor of Bruton’s Tyrosine Kinase (BTK). It is specifically designed to treat various B-cell malignancies by disrupting the signaling pathways that allow cancer cells to grow and survive. Key Indications: Waldenström’s Macroglobulinemia (WM) Mantle Cell Lymphoma (MCL) (in patients who have received at least one prior therapy) Marginal Zone Lymphoma (MZL) Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) ⚙️ Mechanism of Action (How it Works) BTK Inhibition: Zanubrutinib forms a covalent bond with a specific residue in the BTK active site. Pathway Disruption: By inhibiting BTK, Brukinsa blocks the B-cell antigen receptor (BCR) signaling pathway. Stopping Proliferation: This disruption prevents the activation, proliferation, and survival of malignant B-cells, effectively halting the progression of the lymphoma. 📦 Storage & Handling Temperature: Store at room temperature between 20°C to 25°C (68°F to 77°F). Protection: Keep the capsules in their original container to protect them from moisture and light. Safety: Ensure the medication is stored out of reach of children and pets. ⚠️ Potential Side Effects Common: Upper respiratory tract infections, decreased neutrophil count (neutropenia), decreased platelet count (thrombocytopenia), and bruising. Gastrointestinal: Diarrhea and nausea. Musculoskeletal: Muscle and joint pain. Serious: Hemorrhage, infections, and atrial fibrillation/flutter (heart rhythm issues). 🤝 Why Partner with Ernest Impex? Verified Quality: All products are sourced from GMP-certified facilities. Logistics Expertise: We handle the entire global supply process, including customs clearance and cold-chain integrity. Full Documentation: We provide COA (Certificate of Analysis) and technical dossiers for regulatory compliance. Direct Export: Ernest Impex manages all logistics directly from India—you do not need to worry about the export process. ⚖️ Disclaimer: This information is for educational and B2B purposes only and does not constitute medical advice. Brukinsa must only be administered under the supervision of a qualified oncologist. 📞 Contact ERNEST IMPEX — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com | www.ernestvision.com | www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 WhatsApp Link: https://wa.me/919359902383

Carfizome 60 mg Injection: Advanced Proteasome Inhibitor for Relapsed Multiple Myeloma Are you looking for a globally recognized Carfizome 60 mg injection exporter from India? Ernest Impex, a premier division of the Group of Ernest Pharmaceutical Pvt. Ltd., stands at the forefront of oncology medicine distribution. We specialize in providing high-standard pharmaceutical logistics and secure bulk supply to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Extensive Product Profile: Understanding Carfizome 60 mg Carfizome 60 mg Injection, manufactured by the renowned Natco Pharma Ltd., contains the active therapeutic agent Carfilzomib. It is a second-generation selective proteasome inhibitor developed to overcome resistance seen in earlier therapies. This medication is essential for patients with Multiple Myeloma who have previously undergone multiple lines of treatment. 1. Clinical Indications & Primary Usage Relapsed or Refractory Multiple Myeloma (RRMM): Used as a monotherapy for patients whose disease has progressed after at least two prior therapies. Combination Therapy: Frequently prescribed alongside Dexamethasone or Lenalidomide plus Dexamethasone (KRd regimen) to improve progression-free survival in patients who have received one to three prior lines of therapy. 2. Detailed Mechanism of Action: Proteasome Blockade Irreversible Binding: It selectively and irreversibly binds to the N-terminal threonine-active sites of the 20S proteasome, which is the core particle responsible for protein degradation within cells. Protein Overload: By inhibiting the proteasome, the medication prevents the breakdown of “junk“ or misfolded proteins. This leads to a massive accumulation of polyubiquitinated proteins within the cancer cell. Cell Cycle Arrest & Apoptosis: The resulting proteotoxic stress triggers the cell cycle to stop and initiates apoptosis (programmed cell death). Because malignant plasma cells produce high levels of proteins (antibodies), they are significantly more sensitive to this blockade than healthy cells. 3. Administration Guide Route: Intravenous (IV) infusion only. Duration: Typically administered over 10 to 30 minutes, depending on the dosage and patient tolerability. Hydration: Adequate hydration (oral and IV) is mandatory before and after the dose to prevent renal toxicity and Tumor Lysis Syndrome (TLS). Cardiovascular Risks: New or worsening heart failure, hypertension, and myocardial infarction. Respiratory Issues: Shortness of breath (dyspnea) and cough. Hematological Disorders: Decreased levels of red blood cells (anemia), platelets (thrombocytopenia), and white blood cells (neutropenia). Renal Toxicity: Increased serum creatinine and potential kidney impairment. Systemic Reactions: Fatigue, fever, nausea, and infusion-related reactions (chills, joint pain). Storage, Handling, and Stability Protocols Temperature Control: Unopened vials must be stored under refrigeration between 2°C to 8°C (36°F to 46°F). Light Protection: Keep the vial in the original carton to protect it from light. Reconstitution Stability: Once reconstituted with Sterile Water for Injection, the solution is stable for 24 hours under refrigeration or 4 hours at room temperature. Transportation: Must be shipped using cold chain logistics to maintain molecular stability. PRESCRIPTION MEDICINE IS : YES Disclaimer: The information provided here is for professional educational and trade purposes only. Carfizome (Carfilzomib) is a high-potency chemotherapy agent and must only be administered by a qualified oncologist in a specialized clinical setting. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com | www.ernestvision.com www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383 Potential Side Effects of Carfizome 60 mg

Lenmid 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Lenmid 5mg? Lenmid 5mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Lenmid is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Lenmid Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Lenmid prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Lenmid is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict safety program (such as REMS). Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C. Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Lendomy 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Lendomy 5mg? Lendomy 5 mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Lendomy is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Lendomy Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Lendomy prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Lendomy is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict safety program (such as REMS). Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C. Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access high-quality Indian pharmaceutical exports at cost-effective rates. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Laviat 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Laviat 5mg? Laviat 5mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Laviat is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Laviat Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Laviat prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Laviat is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict safety program (such as REMS). Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C. Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Celomide 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Celomide 5mg? Celomide 5 mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Celomide is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Celomide Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Celomide prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration Dosing Schedule: Celomide is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict Risk Evaluation and Mitigation Strategy (REMS) or equivalent safety program. Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, UAE, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost-advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Svitinib 12.5mg Capsule (Sunitinib) Detailed Product Information: What is Svitinib 12.5 mg? Svitinib 12.5 mg is an advanced oral oncology medication containing the active pharmaceutical ingredient sunitinib. It belongs to a specialized class of drugs known as tyrosine kinase inhibitors (TKIs). Svitinib is a “multi-targeted“ therapy, meaning it interferes with specific pathways that cancer cells use to grow, divide, and spread throughout the body. The 12.5mg dosage is often utilized for precise dose titration, allowing oncologists to adjust treatment based on patient tolerance and therapeutic response, ensuring a balanced approach to efficacy and safety. Primary Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): A primary treatment for advanced or metastatic kidney cancer. Gastrointestinal Stromal Tumor (GIST): Used for patients with stomach or bowel tumors that have progressed or for those who cannot tolerate other treatments. Pancreatic Neuroendocrine Tumors (pNET): Specifically for progressive, well-differentiated tumors located in the pancreas. Adjuvant Treatment: Helps prevent the recurrence of kidney cancer in high-risk patients following surgical removal of the kidney. Mechanism of Action: How Svitinib Works Signal Inhibition: It blocks the Tyrosine Kinase enzymes found on the surface of cancer cells. These enzymes act as communication signals; by blocking them, Svitinib prevents the “growth“ command from reaching the cell nucleus, halting uncontrolled cell division. Anti-Angiogenesis: It targets VEGF (Vascular Endothelial Growth Factor) and PDGF (Platelet-Derived Growth Factor) receptors. This prevents the tumor from growing new blood vessels. By cutting off these “nutrient supply lines,“ the tumor is starved of oxygen and nutrients. Metastasis Suppression: By disrupting cellular signaling, it inhibits the ability of malignant cells to migrate from the primary site to other organs. Detailed Clinical Instructions Dosage: Always follow the exact dosage and cycle prescribed by your oncologist. The 12.5mg dose is often used for precise titration. Administration: Swallow the capsule whole with water. You may take it with or without food. Integrity: Do not crush, chew, or open the capsule, as this can affect drug absorption and increase the risk of side effects. Consistency: Take your dose at the same time every day to maintain steady blood levels. Cycle Management: Svitinib is frequently taken in cycles (e.g., 4 weeks on, 2 weeks off). Do not skip days unless instructed by a physician. Dietary Note: Avoid grapefruit and grapefruit juice, as they can significantly increase the levels of Sunitinib in your blood to unsafe levels. Potential Side Effects Gastrointestinal: Nausea, diarrhea, vomiting, and mouth sores (stomatitis). Dermatological: Skin discoloration (often a yellowish tint), dryness, or Hand-Foot Syndrome (painful redness and swelling on the palms and soles). Cardiovascular: High blood pressure (hypertension). Regular monitoring is essential. Systemic: Fatigue, weakness, and decreased appetite or altered taste (dysgeusia). Hematological: Potential for decreased white blood cell or platelet counts, requiring periodic blood monitoring. Storage and Handling Requirements Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Safety: Keep strictly out of reach of children and pets. Waste Management: Do not dispose of oncology medications in household wastewater. Consult your local pharmacist for proper hazardous waste disposal. Why Choose Ernest Impex? ✔ GMP Quality: We ensure all oncology products meet the highest international manufacturing standards. ✔ Worldwide Strategic Logistics: Expertise in shipping to USA, UK, Thailand, Australia, Singapore, and Jamaica. ✔ Bulk Supply Specialist: A reliable partner for hospital procurement, oncology centers, and wholesale distributors. ✔ Competitive Export Pricing: Access high-quality Indian pharmaceutical exports at cost-effective rates. ✔ Documentation Support: We provide full assistance with COA, invoices, and customs documentation for seamless delivery. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Sutykine 12.5 mg Capsule (Sunitinib) Comprehensive Product Profile: What is Sutykine 12.5mg? Sutykine 12.5 mg is a high-potency oral oncology medication containing the active pharmaceutical ingredient Sunitinib. It belongs to a specialized class of drugs known as Tyrosine Kinase Inhibitors (TKIs). Sutykine is a “multi-targeted“ therapy, designed to identify and interfere with specific molecular pathways that allow tumors to survive, grow, and spread throughout the body. The 12.5mg dosage is often essential for precise clinical titration, allowing oncologists to adjust the treatment regimen based on individual patient tolerance and the specific stage of the malignancy. Primary Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): Used as a standard first-line treatment for advanced kidney cancer. Gastrointestinal Stromal Tumors (GIST): For patients with stomach or bowel tumors that have progressed or who are intolerant to previous therapies. Pancreatic Neuroendocrine Tumors (pNET): Treats progressive, well-differentiated tumors located in the pancreas. Adjuvant RCC Therapy: Used to reduce the risk of cancer returning following a nephrectomy in high-risk patients. Mechanism of Action: How Sutykine Works Kinase Inhibition: It blocks enzymes called Tyrosine Kinases found on the surface of cancer cells. These enzymes act as communication signals; by blocking them, Sutykine prevents the “growth“ command from reaching the cell nucleus, halting uncontrolled cell division. Anti-Angiogenesis Strategy: It targets the Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF) receptors. This inhibits the growth of new blood vessels. By cutting off these “nutrient supply lines,“ the tumor is starved of oxygen and essential nutrients. Metastasis Suppression: By disrupting vital survival pathways, the medication can trigger programmed cell death (apoptosis) in malignant tissues and prevent the spread to distant organs. Detailed Clinical Instructions & Administration Dosing Schedule: Sutykine is typically administered in cycles (e.g., 4 weeks of daily treatment followed by a 2-week rest period). Strictly adhere to the specific cycle prescribed by your oncologist. Administration: Swallow the capsule whole with water. It can be taken with or without food. Integrity: Do not crush, chew, or open the capsule, as this can affect the absorption rate and increase the risk of side effects. Consistency: Take your dose at the same time every day to maintain a steady concentration in your system. Dietary Note: Avoid grapefruit and grapefruit juice, as they can significantly increase the levels of Sunitinib in your blood to unsafe levels. Management of Potential Side Effects Gastrointestinal: Nausea, diarrhea, vomiting, and “stomatitis“ (mouth sores). Dermatological: Yellowish skin discoloration (non-jaundice), dryness, or Hand-Foot Syndrome (painful redness and swelling on the palms and soles). Cardiovascular: Hypertension (high blood pressure) is common; regular monitoring is essential. Endocrine: Changes in thyroid function (Hypothyroidism) or altered taste (dysgeusia). Hematological: Potential decrease in white blood cell or platelet counts, requiring periodic blood monitoring. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature Range: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Child Safety: Keep strictly out of reach of children. Waste Management: Do not dispose of unused capsules in household wastewater. Consult your local pharmacist for proper oncology drug disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Thailand, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Sutib 12.5mg Capsule (Sunitinib) Detailed Product Information: What is Sutib 12.5mg? Sutib 12.5mg is a high-potency oral oncology medication containing the active ingredient Sunitinib. It belongs to a sophisticated class of drugs known as Tyrosine Kinase Inhibitors (TKIs). Sutib is a “multi-targeted“ therapy, designed to identify and interfere with specific molecular pathways that cancer cells use to grow, divide, and spread throughout the body. The 12.5mg dosage is essential for precise clinical titration, allowing oncologists to tailor the treatment regimen based on individual patient tolerance and the specific stage of the malignancy. Primary Therapeutic Indications : Advanced Renal Cell Carcinoma (RCC): Used as a primary treatment for advanced kidney cancer. Gastrointestinal Stromal Tumors (GIST): For patients with stomach or bowel tumors that have progressed or who are intolerant to previous therapies. Pancreatic Neuroendocrine Tumors (pNET): Treats progressive, well-differentiated tumors located in the pancreas. Adjuvant RCC Therapy: Reduces the risk of cancer returning following a nephrectomy in high-risk patients. Mechanism of Action: How Sutib Works: Signal Inhibition: It blocks enzymes called Tyrosine Kinases found on the surface of cancer cells. These enzymes act as communication signals; by blocking them, Sutib prevents the “growth“ command from reaching the cell nucleus. Anti-Angiogenesis: Sutib inhibits the Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF) receptors. This prevents the tumor from growing new blood vessels. By cutting off these “nutrient supply lines,“ the tumor is starved of oxygen and essential nutrients. Apoptosis Induction: By disrupting vital survival pathways, the medication can trigger programmed cell death (apoptosis) in malignant tissues. Clinical Instructions & Administration : Dosing Schedule: Sutib is typically administered in cycles (e.g., 4 weeks of daily treatment followed by a 2-week rest period). Strictly adhere to the specific cycle prescribed by your oncologist. Administration: Swallow the capsule whole with water. It can be taken with or without food. Integrity: Do not crush, chew, or open the capsule, as this can affect the absorption rate and increase the risk of side effects. Consistency: Take your dose at the same time every day to maintain a steady concentration in your system. Dietary Note: Avoid grapefruit and grapefruit juice, as they can significantly increase the levels of Sunitinib in your blood to unsafe levels. Management of Potential Side Effects L: Gastrointestinal: Nausea, diarrhea, vomiting, and mouth sores (stomatitis). Dermatological: Yellowish skin discoloration (non-jaundice), dryness, or Hand-Foot Syndrome (painful redness and swelling on the palms and soles). Cardiovascular: Hypertension (high blood pressure) is common; regular monitoring is essential. Metabolic: Changes in thyroid function (Hypothyroidism) or altered taste (dysgeusia). Hematological: Potential decrease in white blood cell or platelet counts, requiring periodic blood monitoring. Storage and Handling Requirements : Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Safety: Keep strictly out of reach of children. Handle with care; if a capsule breaks, avoid breathing in the powder or getting it on your skin. Disposal: Do not dispose of oncology medications in household wastewater. Consult your local pharmacist for proper hazardous waste disposal. Why Choose Ernest Impex? ✔ GMP Quality: We ensure all oncology products meet the highest international manufacturing standards. ✔ Global Strategic Logistics: Specialized handling for pharmaceutical shipments to the USA, UK, Australia, and Singapore. ✔ Bulk Supply Specialist: A reliable partner for hospital procurement, oncology centers, and wholesale distributors. ✔ Competitive Export Pricing: Access high-quality Indian pharmaceutical exports at cost-effective rates. ✔ Documentation Support: We provide full assistance with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Lenome 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Lenome 5mg? Lenome 5 mg is a potent oral medication containing the active pharmaceutical ingredient Lenalidomide. It is classified as an Immunomodulatory Imide (IMiD) and is a cornerstone in modern hematology-oncology. Lenome is designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly interfering with the growth of malignant cells. Primary Therapeutic Indications : Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy after a stem cell transplant. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Lenome Works : Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Lenome prevents the formation of new blood vessels that tumors need to grow. By cutting off these “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive and proliferate. Detailed Clinical Instructions & Administration: Dosing Schedule: Lenome is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict Risk Evaluation and Mitigation Strategy (REMS) or equivalent safety program. Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols : Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, UAE, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Lynide 5mg Capsule (Lenalidomide) Comprehensive Product Profile: What is Lynide 5mg? Lynide 5 mg is a potent oral medication containing the active ingredient Lenalidomide. It belongs to a specialized class of drugs known as Immunomodulatory Imides (IMiDs). Lynide is a cornerstone in modern hematology-oncology, designed to treat specific types of blood cancers and bone marrow disorders by altering the immune system's response and directly targeting malignant cells. Primary Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for patients with multiple myeloma, often as a first-line treatment or for maintenance therapy. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with rituximab for previously treated patients. Mechanism of Action: How Lynide Works Tumor Cell Apoptosis: It directly inhibits the growth of tumor cells by inducing “programmed cell death“ (apoptosis). Anti-Angiogenesis: Lynide prevents the formation of new blood vessels that tumors need to grow. By cutting off the “nutrient supply lines,“ it effectively starves the tumor. Immune Enhancement: It stimulates the body's T-cells and Natural Killer (NK) cells, empowering the immune system to identify and destroy cancer cells more efficiently. Cytokine Modulation: It alters the production of cytokines (chemical messengers), reducing pro-inflammatory signals that help cancer cells survive. Detailed Clinical Instructions & Administration Dosing Schedule: Lynide is typically taken in cycles (e.g., 21 days of treatment followed by a 7-day rest period). Strictly follow the specific cycle prescribed by your hematologist. Administration: Swallow the 5mg capsule whole with water. It can be taken with or without food, but try to take it at the same time every day. Integrity: Do not open, break, or chew the capsules. If the powder inside a capsule is touched, wash the area immediately with soap and water. Pregnancy Prevention: Because Lenalidomide can cause severe birth defects, patients must adhere to a strict Risk Evaluation and Mitigation Strategy (REMS) or equivalent safety program. Management of Potential Side Effects Hematological: Neutropenia (low white blood cells), Thrombocytopenia (low platelets), and Anemia. Regular blood counts are essential. Thromboembolism: Increased risk of blood clots in the veins (DVT) or lungs (PE). Oncologists often prescribe blood thinners as a precaution. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. Dermatological: Rashes or itching (pruritus). Systemic: Fatigue, fever, and muscle cramps. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Child Safety: Keep strictly out of reach of children. Hazardous Waste: Do not dispose of unused capsules in household wastewater. Return unused medication to your healthcare provider for proper biohazardous disposal. Why Choose Ernest Impex? ✔ GMP Standards: We ensure all oncology products meet rigorous international manufacturing benchmarks. ✔ Global Logistics Expertise: Specialized handling for pharmaceutical shipments to the USA, UK, Thailand, and Singapore. ✔ B2B Bulk Specialization: A reliable partner for hospital procurement, oncology clinics, and wholesale distributors. ✔ Competitive Export Pricing: Access high-quality Indian pharmaceutical exports at cost-effective rates. ✔ Documentation Support: Full assistance with COA (Certificate of Analysis), invoices, and customs documentation. We Export Impex Medicines to: USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383

Sutekast 12.5 mg Capsule (Sunitinib) Detailed Product Information: What is Sutekast 12.5mg? Sutekast 12.5 mg is a high-potency oral oncology medication containing the active pharmaceutical ingredient Sunitinib. It is classified as a multikinase inhibitor (TKI) and represents a landmark shift in personalized cancer care. Unlike traditional chemotherapy that non-selectively attacks all rapidly dividing cells, Sutekast is designed to identify and interfere with specific molecular pathways that allow tumors to survive, grow, and spread. The 12.5mg dosage is often utilized for precise dose titration, allowing oncologists to adjust treatment based on patient tolerance and therapeutic response, ensuring a balanced approach to efficacy and safety. Primary Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): Widely recognized as a standard therapy for advanced or metastatic kidney cancer. Gastrointestinal Stromal Tumors (GIST): Utilized for patients with stomach or bowel tumors that have progressed despite previous therapies. Pancreatic Neuroendocrine Tumors (pNET): Treats progressive, well-differentiated tumors located in the pancreas. Adjuvant Treatment: Used to reduce the risk of cancer recurrence following surgery in high-risk kidney cancer patients. Mechanism of Action: How Sutekast Works Tyrosine Kinase Inhibition: It blocks enzymes known as Tyrosine Kinases found on the surface of cancer cells. These enzymes act as “on-switches“ for growth. By locking these switches in the “off“ position, Sutekast stops the signals that tell cancer cells to multiply. Anti-Angiogenesis Strategy: Sutekast targets Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF) receptors. This inhibits the growth of new blood vessels. By cutting off the “nutrient supply lines,“ the tumor is starved of oxygen and essential nutrients. Metastasis Suppression: By disrupting vital survival pathways, the medication can trigger programmed cell death (apoptosis) in malignant tissues and help prevent the spread to other organs. Detailed Clinical Instructions Dosing Schedule: Sutekast is typically administered in cycles (e.g., 4 weeks of daily treatment followed by a 2-week rest period). Strictly adhere to the specific cycle prescribed by your oncologist. Administration: Swallow the 12.5mg capsule whole with water. It can be taken with or without food. Integrity: Never crush, chew, or open the capsule, as this can affect the absorption rate and increase the risk of side effects. Consistency: Take your dose at the same time every day to maintain a steady concentration of the drug in your system. Dietary Note: Avoid grapefruit and grapefruit juice, as they can significantly increase the levels of Sunitinib in your blood to unsafe levels. Management of Potential Side Effects Gastrointestinal: Nausea, diarrhea, vomiting, and “stomatitis“ (mouth sores). Dermatological: Yellowish skin discoloration (non-jaundice), dryness, or Hand-Foot Syndrome (painful redness and swelling on the palms and soles). Cardiovascular: Hypertension (high blood pressure) is common; regular monitoring is essential. Endocrine: Changes in thyroid function (Hypothyroidism) or altered taste (dysgeusia). Hematological: Potential decrease in white blood cell or platelet counts, requiring periodic blood monitoring. Storage and Handling Protocols Environmental Control: Store in a cool, dry place away from direct sunlight and humidity. Temperature Range: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Child Safety: Keep strictly out of reach of children. Waste Management: Do not dispose of unused capsules in household wastewater. Consult your local pharmacist for proper oncology drug disposal. Why Partner with Ernest Impex? ✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks. ✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, Thailand, Australia, and Singapore. ✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors. ✔ Competitive Export Pricing: Access the cost-advantages of the Indian pharmaceutical market without compromising on quality. ✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation. We export Impex medicines to the following: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia 📞 Contact Ernest Impex – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com www.oncologuymediciensupplier.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Chat: https://wa.me/919359902383